Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
XBI and markets up big and yet ADMP flat. I was wrong, thought they were correlated. Damn 1 minute chart. Not sure why its not helping with my investing. Must be my chart reading.
Well, it's clear the directors are trying to screw shareholders again w/ the RS....there are many shareholders banding together to vote no, so there is a chance to vote it down - every vote counts. If you haven't received the proxy, you can call your brokerage firm to get a control # to vote.
I have 30,000 shares and didn’t receive crap !! Does the voting even matter ? We voted the knuckle head ceo out, what was it. 3 years ago ? and he wasn’t removed ! At that time I think he was the only one on the board that had the votes to be kicked off. Nothing happened.
Full disclosure >>> I actually voted NO for all except auditors.
R/S is NOT a given here. Anyone here that is an actual shareholder should have received their proxy by now. VOTE NO ON R/S and COMPENSATION (I voted NO across the board - as did many other retail holders). We can stop this.
It's actually a joke, ADMP that is. Why? COVID has been raging forever now. Tempol has decades of safety data. All they could put together was a tiny study. Also, as ppl die no emergency designation? Strange. Now, ADMP trying, and will succeed, to get a R/S done. Again, why? You supposedly have the holy grail of Covid treatment. You supposedly have a drug that will save all addicts from overdoses. Finally, you have an affordable insulin product for the masses of the world that blows always their competitors pricing. Why then, with all this fantastic public news, does ADMP's pps sit at .50 and can't gain any traction. But, but, but...
R/S coming. Does ADMP management know something about Tempol that isn't good? What about Zimhi? Or their insulin product?
We are being told 3 drugs to change the world and pps at .50. Does that sound right to you? To me its a huge red flag but what do I know, I use the 1 min chart for investing.
'US orders 3.2M Novavax COVID-19 vaccine doses'
So Tempol has decades of safety and still no emergency designation. People getting sick and dying yet a safe drug that appears to help with COVID symptons is still not available. RED FLAG! What a joke this investment has been. Damn 1 min chart let me down!
I now have 35,500 shares of this POS company. I need lighting to strike with Tempol but I'm not hopeful. The ONLY reason I have this many shares is a lotto play on the data surrounding the Tempol trials which they refuse to share. I was hoping to be out of this name by now but holding my nose a bit longer. This is a horribly wrong company and at this point I regret ever buying it. Wish I bought this much of Veru instead:(
Who needs Tempol:) Remember, I posted about Veru. This was the name to trade in. This was a winner. $4ish to $13ish. What has ADMP done?
"Cancer drug cut risk of death for hospitalized COVID patients in study"
https://www.yahoo.com/news/cancer-drug-cut-risk-death-214816636.html
More evidence Zihmi will be a dud
GoodRX pricing
- Zimhi - Two prefilled .5 needles = Best price $131
- Nasal Spray - Two .4 sprays = $52
MORE THAN DOUBLE! But, but, but Zimhi is .5, only matters if emergency personnel are standing right next to person over dosing. Timing is critical for injection to be more effective. Geesh (ha)!
Per Yahoo Finance, "ZIMHIDirect.com is subject to terms and conditions including a minimum order quantity of one case of ZIMHI (12 units)." I guess they aren't too focused on the retail customer, aka users and their friends and family, with this requirement via this portal. Wonder what discount they are giving to the big buyers? Will it be enough to persuade them to switch from nasal? Probably not. Plus they don't want to be the guinea pigs for a new product when the current one works real well.
C'mon Tempol, it's all up to you or my shares bleed to death as ADMP goes nowhere but down. LOL
50% net revenue sharing on symjepi and zimhi, both which will probably sell poorly, won't make shareholders $$$. So many red flags around Tempol...we need a miracle.
The ADMP dam is starting to break, watch out below!
Decades of safety data in Tempol and yet no emergency designation so that lives could be saved. Why? This is a red flag for an objective observer of ADMP. It's all or nothing with Tempol.
Will lighting strike?
Sure, please show me the numbers that Zimhi is even close to outpacing the nasal application sales of narcan. Love to be proven wrong with facts. Geesh (ha)! eom:)
I'm all about the 1 min chart and the 1 level.
Hahaha better check the numbers.
I agree it will not sell well.
But but but Roll, it will never sell. It’s Narcan…. Hahaha. This company will be the number 1 dealer of Narcan soon. They have the N Jab!! Let’s go!!!!it will be the go to. Book it!
A PR with no meat. Business as usual. NASDAQ up nicely. ADMP well below the $1 floor. Zimhi will struggle against the existing and well established nasal application for narcan.
ADMP's partner USWM PR'd..............
https://www.globenewswire.com/news-release/2022/07/05/2474234/0/en/US-WorldMeds-Launches-ZIMHIDirect-com.html
In a down market across the boards it is hard to get a rise outta anything unless revenue related or an upfront payment from a contract or partner.Aug will tell what ZIMHI sales have been.Last Q they had net profit to each ADMP and USWM at 1.1 million for 30 days after launch,,,That means(hard to say what profit margin is) but at least 2.2 million is sales for the naysayers because the split NET PROFIT 50/50 so sales could of been say 3 million minus costs...Time will tell the story Tic Toc......
Thanks Roll.......
Facts are fact. Weak sales and weak demand. As stated Zimhi is not a better mouse trap, only in theory but not in a practical real life application. This has not been disputed.
As for Tempol, a TINY study that is taking forever AND if so safe why no emergency designation? Makes NO SENSE as ppl die our government is not willing to give a drug that has been around for decades and has been deemed safe. This is insane and makes NO sense. Something isn't lining up.
I'm the best investor in the world. I'm never wrong and all my selections for investments are based on my awesome judgement using 1 minute charts. When something goes in an opposite direction of what I say its just someone elses fault and I'm still right. Look at my calls, so many of them, always right. I'm money! $1 is holding strong. Geesh! eom;)
Sure......FDA just decided to give ADMP Full FDA Approval for ZIMHI....
When there is 13 others selling naloxone...because they all are the same???Geesh! ZIMHI is number 1 go to for the strongest of them all....and sales in August will be better than most think with DOD contract......
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-naloxone-injection-counteract-opioid-overdoses
As you see,the greater mg number means you are delivering "MORE" all at once.So to say they are equal is not accurate....by any means..SAFE mean patients CAN handle the extra mg when administered OR FDA would not of approved ZIMHI...
Thanks Roll......Tuesday could be news on ADMP..Many things other than Tempol results such as Symjepi back on market......Nasdaq extension granted......USC sold in AR finally....take your pick......not to mention something coming from USWM as to DOD contract.......
Again, if you read the data provided Zimhi is ONLY an advantage if the drug is administered immediately upon overdose. The more time that goes by this 'advantage' disappears. Facts versus emotions.
It's all or nothing for ADMP with Tempol. I got my lottos calls and shares in case lighting strikes but I'm only here for one reason and its been a rolling mission success. I'm 2 for 2;)
Zimhi is the highest dose of Narcan on the market. On a positive note, many will want the best and strongest. Like when I buy condoms for protection I like the strongest, same as my Narcan. Zimhi will move the needle. No pun.
Emergency personnel are NOT next to victim at moment of overdose. The majority of city, state and federal groups that carry narcan won't be next to the victim at moment of overdose. This fact removes any advantage that Zimhi MIGHT have over the nasal application.
Zimhi isn't going to gain traction with the big buyers. ADMP's insulin sales are lackluster. Tempol has to deliver or ADMP is going nowhere.
As a non responder I’d rather stab a leg and get away than have my fingers next to a dirty mouth that could come back alive and bite the shat out of me. Has no one seen zombie apocalypse? Moms Neighbor John Wayne Casy saw it just last night.
And yep, as a first responder, I doubt we ever consider zimhi cause of the potential for a needle stick.
And the nasal spray 'works'. I am aware that some say zimhi has a faster 'reaction' than Narcan thru the nose. But I have yet to see any evidence backing up this claim.
But again, given how a patient in a drug overdose 'wakes up' and tends to be violent, I doubt many will want to be dealing trying to cover up a needle with a patient who's about to take a swing at them..
Worth repeating..Zimhi and Narcan contain the same medications. LOL
Facts do help, here are some that took 2 seconds to find...
'Zimhi is a new injectable version of naloxone used for opioid overdose. Narcan is also naloxone, but it’s a nasal spray that’s been available since 2015.'
https://www.goodrx.com/naloxone/zimhi-vs-narcan-comparing-treatments-for-opioid-overdose
Different altogether. One is an injectable the other is intranasal. Fact check.
"'The worst version' of COVID is spreading. Can we update our vaccines in time?"
I don't believe any of these clowns but at least we have the 'holy grail', Tempol, to fight off this new wave of attack;)
https://www.yahoo.com/news/the-worst-version-of-covid-is-spreading-can-we-update-our-vaccines-in-time-131933423.html
You do realize that Zimhi and Narcan contain the same medications so if a shortage of one then shortage of both.
There is a shortage of narcan and Zimhi will get a foot hold. Look at all the angles whenever investing hard earned money is what mom’s neighbor John Wayne Casy always says. That’s a positive 1mibute lesson
Zimhi isn't saving shareholders. It won't be able to cut through the bureaucracies anytime soon especially considering how well the nasal application has been for a LONG time. Only benefit of the needle is if you are standing next to the person as they overdose. If not, makes no difference. The large organizations who would be buying large quantities of narcan understand this and will pass on it. Its not a better mousetrap. Applying emotions to my investing won't make me money, just lose it. This is why I use the 1 minute chart for investing. LOL. eom;)
On a positive note… Zimhi will save the day!!
Isn't it funny how quickly so many other COVID drugs have been pushed through the system and yet the 'holy grail' of COVID treatment has been stuck in the mud. Decades of safety and yet even the King of Covid himself isn't able to use it. People are dying every day and this safe and supposedly effective drug isn't even granted emergency use. Why is that? Decades of safety data and it can't even get emergency designation. Was worth the repeat. Something is up. Maybe Tempol sucks. BUT, BUT, BUT...eom;)
Is this turd going to eventually make its way back up ?
Yes, I own ADMP which is basically like saying I own a steamy pile of...
I love vibes that make money. ADMP, not so much. We should know by 2025 if Tempol will deliver for severe hemorrhoid treatment or not. At least maybe they will find some use outside of Covid for Tempol.
Know what you own! We take off soon!
Great post Rolgard, love the positive vibes you bring to the room!
Interesting, yet there was no such requirement placed on TMDI so something clearing isn't lining up as it relates to commentary around ADMP r/s.
ADMP has to include the r/s language per nasdaq requirement........
Read this part from PRE-14A.......as r/s MUST be in there part of their written plan...So it has to be offered in the proxy language since shareholders only vote 1 time a year annual..I am sure ADMP does not want to put it in there but according to Nas requirement is has to be-unless you see something I am missing.Thanks Roll.......
To qualify for additional time, we would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and would need to provide written notice of a plan to cure the deficiency during the second compliance period, including by effecting a reverse stock split if necessary. If we meet these requirements, Nasdaq would inform us that we have been granted an additional 180 calendar days to regain compliance. However, if it appears to the staff of Nasdaq that we will not be able to cure the deficiency, or if we are otherwise not eligible, the staff would notify us that we will not be granted additional 180 days for compliance and will be subject to delisting at that time. In the event of such notification, we may appeal the staff’s determination to delist our securities, but there can be no assurance that any such appeal would be successful.
So straight from their Filing.......In 2020 a r/s was voted down.Tutes own around 14/15 million shares still today..So??
Nothing says strength more than a R/S. Trust me, I use a 1 minute chart when I do my investing;)
Nasal injections? Hahaha.
Nasal sprays are fully embedded in various organizations and institutions. I'm positive it will have trouble cutting through the bureaucracy plus the nasal injections are highly effective.
It's an all or nothing for ADMP with Tempol and we should know about that by end of 2025.
Moms Neighbor John Wayne Casy says there’s a fentanyl epidemic and Adamis is going to sell the shots out of Zimhi. He’s a positive guy. Hahahaha.
ADMP remains Tempol or nothing. ADMP isn't worth much if Tempol is a failure. Numbers don't lie.
Followers
|
136
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
4271
|
Created
|
08/03/02
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |